"10.1371_journal.pone.0079067","plos one","2013-11-01T00:00:00Z","Sugata Hazra; Valerie Stepps; Ashay D Bhatwadekar; Sergio Caballero; Michael E Boulton; Paul J Higgins; Elena V Nikonova; Carl J Pepine; Catherine Thut; Eva M Finney; David J Stone; Stephen H Bartelmez; Maria B Grant","Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, United States of America; BetaStem Therapeutics, Inc, San Francisco, California, United States of America; Department of Anatomy and Cell Biology, University of Florida, Gainesville, Florida, United States of America; Center for Cell Biology and Cancer Research, Albany Medical College, Albany, New York, United States of America; Exploratory and Translational Sciences, Merck Research Laboratories, Merck & Co. Inc,West Point, Pennsylvania., United States of America; Department of Medicine, University of Florida, Gainesville, Florida, United States of America","Conceived and designed the experiments: SH ADB SC SHB MBG. Performed the experiments: SH VS ADB SC EVN CT EMF DJS. Analyzed the data: SH VS ADB SC EVN CT EMF DJS SHB. Contributed reagents/materials/analysis tools: MEB SHB PJH CJP MBG. Wrote the manuscript: SH SC SHB MBG.","We have the following interests. This study was partly funded by Merck & Co. and and AVI-Biopharma Inc. Valerie Stepps is employed by BetaStem Therapeutics, Inc and Stephen H. Bartelmez is the owner of this company. The technology described in this manuscript is being developed by BetaStem Therapeutics, Inc. Elena V.Nikonova, Catherine Thut, Eva M Finney and David J, Stone are employed by Merck Research Laboratories. Michael Boulton is a PLOS ONE Editorial Board member. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the
PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Sugata Hazra","SH",13,TRUE,5,8,9,4,TRUE,TRUE,FALSE,0,NA,FALSE
